vs
GREAT SOUTHERN BANCORP, INC.（GSBC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是GREAT SOUTHERN BANCORP, INC.的1.2倍（$69.8M vs $56.4M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 28.9%，领先355.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -0.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 4.5%）
该企业是美国的多元化银行金融机构，总部位于明尼苏达州明尼阿波利斯，在特拉华州注册。截至2025年，它是美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构，主营零售及企业银行业务、投资、抵押贷款等多元金融服务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
GSBC vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.2倍
$56.4M
营收增速更快
RIGL
高出21.4%
-0.2%
净利率更高
RIGL
高出355.2%
28.9%
两年增速更快
RIGL
近两年复合增速
4.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $56.4M | $69.8M |
| 净利润 | $16.3M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 34.5% | 33.2% |
| 净利率 | 28.9% | 384.0% |
| 营收同比 | -0.2% | 21.2% |
| 净利润同比 | 9.1% | 1769.2% |
| 每股收益（稀释后） | $1.44 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GSBCRIGL
| Q4 25 | $56.4M | $69.8M | ||
| Q3 25 | $57.8M | $69.5M | ||
| Q2 25 | $59.2M | $101.7M | ||
| Q1 25 | $55.9M | $53.3M | ||
| Q4 24 | $56.5M | $57.6M | ||
| Q3 24 | $55.0M | $55.3M | ||
| Q2 24 | $56.7M | $36.8M | ||
| Q1 24 | $51.6M | $29.5M |
净利润GSBCRIGL
| Q4 25 | $16.3M | $268.1M | ||
| Q3 25 | $17.8M | $27.9M | ||
| Q2 25 | $19.8M | $59.6M | ||
| Q1 25 | $17.2M | $11.4M | ||
| Q4 24 | $14.9M | $14.3M | ||
| Q3 24 | $16.5M | $12.4M | ||
| Q2 24 | $17.0M | $-1.0M | ||
| Q1 24 | $13.4M | $-8.2M |
毛利率GSBCRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率GSBCRIGL
| Q4 25 | 34.5% | 33.2% | ||
| Q3 25 | 38.2% | 40.9% | ||
| Q2 25 | 41.0% | 60.1% | ||
| Q1 25 | 38.4% | 23.9% | ||
| Q4 24 | 31.8% | 28.9% | ||
| Q3 24 | 36.6% | 25.4% | ||
| Q2 24 | 36.8% | 1.2% | ||
| Q1 24 | 32.1% | -23.6% |
净利率GSBCRIGL
| Q4 25 | 28.9% | 384.0% | ||
| Q3 25 | 30.7% | 40.2% | ||
| Q2 25 | 33.4% | 58.6% | ||
| Q1 25 | 30.7% | 21.5% | ||
| Q4 24 | 26.4% | 24.9% | ||
| Q3 24 | 30.0% | 22.5% | ||
| Q2 24 | 30.0% | -2.8% | ||
| Q1 24 | 26.0% | -27.9% |
每股收益（稀释后）GSBCRIGL
| Q4 25 | $1.44 | $14.11 | ||
| Q3 25 | $1.56 | $1.46 | ||
| Q2 25 | $1.72 | $3.28 | ||
| Q1 25 | $1.47 | $0.63 | ||
| Q4 24 | $1.27 | $0.82 | ||
| Q3 24 | $1.41 | $0.70 | ||
| Q2 24 | $1.45 | $-0.06 | ||
| Q1 24 | $1.13 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $189.6M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $636.1M | $391.5M |
| 总资产 | $5.6B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资GSBCRIGL
| Q4 25 | $189.6M | $155.0M | ||
| Q3 25 | $196.2M | $137.1M | ||
| Q2 25 | $245.9M | $108.4M | ||
| Q1 25 | $217.2M | $77.1M | ||
| Q4 24 | $195.8M | $77.3M | ||
| Q3 24 | $208.4M | $61.1M | ||
| Q2 24 | $186.5M | $49.1M | ||
| Q1 24 | $171.4M | $49.5M |
总债务GSBCRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益GSBCRIGL
| Q4 25 | $636.1M | $391.5M | ||
| Q3 25 | $632.9M | $117.6M | ||
| Q2 25 | $622.4M | $81.9M | ||
| Q1 25 | $613.3M | $18.6M | ||
| Q4 24 | $599.6M | $3.3M | ||
| Q3 24 | $612.1M | $-14.6M | ||
| Q2 24 | $568.8M | $-29.9M | ||
| Q1 24 | $565.2M | $-31.7M |
总资产GSBCRIGL
| Q4 25 | $5.6B | $513.6M | ||
| Q3 25 | $5.7B | $242.5M | ||
| Q2 25 | $5.9B | $206.7M | ||
| Q1 25 | $6.0B | $176.0M | ||
| Q4 24 | $6.0B | $164.0M | ||
| Q3 24 | $6.0B | $139.4M | ||
| Q2 24 | $6.0B | $128.4M | ||
| Q1 24 | $5.8B | $126.5M |
负债/权益比GSBCRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $81.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $70.1M | — |
| 自由现金流率自由现金流/营收 | 124.3% | — |
| 资本支出强度资本支出/营收 | 20.3% | — |
| 现金转化率经营现金流/净利润 | 5.01× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $121.9M | — |
8季度趋势，按日历期对齐
经营现金流GSBCRIGL
| Q4 25 | $81.5M | $22.0M | ||
| Q3 25 | $5.6M | $24.0M | ||
| Q2 25 | $39.3M | $30.5M | ||
| Q1 25 | $15.0M | $-893.0K | ||
| Q4 24 | $44.1M | $14.5M | ||
| Q3 24 | $17.7M | $21.7M | ||
| Q2 24 | $43.5M | $302.0K | ||
| Q1 24 | $-26.9M | $-5.0M |
自由现金流GSBCRIGL
| Q4 25 | $70.1M | — | ||
| Q3 25 | $3.9M | — | ||
| Q2 25 | $34.9M | — | ||
| Q1 25 | $13.1M | — | ||
| Q4 24 | $39.1M | — | ||
| Q3 24 | $16.5M | — | ||
| Q2 24 | $42.0M | — | ||
| Q1 24 | $-27.7M | — |
自由现金流率GSBCRIGL
| Q4 25 | 124.3% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | 59.0% | — | ||
| Q1 25 | 23.4% | — | ||
| Q4 24 | 69.3% | — | ||
| Q3 24 | 30.1% | — | ||
| Q2 24 | 74.1% | — | ||
| Q1 24 | -53.7% | — |
资本支出强度GSBCRIGL
| Q4 25 | 20.3% | — | ||
| Q3 25 | 3.0% | — | ||
| Q2 25 | 7.4% | — | ||
| Q1 25 | 3.5% | — | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 1.6% | — |
现金转化率GSBCRIGL
| Q4 25 | 5.01× | 0.08× | ||
| Q3 25 | 0.31× | 0.86× | ||
| Q2 25 | 1.99× | 0.51× | ||
| Q1 25 | 0.87× | -0.08× | ||
| Q4 24 | 2.95× | 1.01× | ||
| Q3 24 | 1.07× | 1.75× | ||
| Q2 24 | 2.56× | — | ||
| Q1 24 | -2.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
